FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

SUPPL AP for HERCEPTIN (TRASTUZUMAB)